KRAS and familial pancreatic carcinoma: These exosomes, when injected intratumorally into an orthotopic model of pancreatic cancer (B6‐albino mice), were found to be effective in reducing tumor growth and Kirsten rat sarcoma viral oncogene homolog (KRAS) mRNA levels.[137] Majeau et al.